Veradigm

MDRX · OTC

$4.75−$0.25 (−5.00%)TodayMarket closed ·
Prev close $5.00

Latest news

  • Press releaseBusiness Wire

    Veradigm Announces Updated Presentation Time for Upcoming Investor Conference

  • Press releasePRNewswire

    Did Veradigm Inc. Insiders Breach their Fiduciary Duties to Shareholders?

  • Press releaseBusiness Wire

    Veradigm to Participate in Two Upcoming Investor Conferences

  • Press releaseBusiness Wire

    Veradigm Files 2023 and 2024 Form 10-K

  • Press releaseBusiness Wire

    Veradigm to Release Business Update May 26th and Host Investor Call May 27th

  • Press releaseBusiness Wire

    Veradigm Launches Health Network Architecture to Level the Playing Field for Independent Practices

  • Press releaseBusiness Wire

    Veradigm Survey: Independent Practices Rely on Technology to Stay Independent

  • Press releaseBusiness Wire

    Veradigm Receives KLAS 2026 Points of Light Award for Embedding SDOH Data in Provider EHR Workflows

  • Press releaseBusiness Wire

    Veradigm Doubles India-Based Employee Footprint, Adds New Managing Director

  • Press releaseBusiness Wire

    Veradigm Appoints Christian Greyenbuhl as Chief Financial Officer

  • Press releaseBusiness Wire

    Veradigm Provides Business and Strategy Update

  • Press releaseBusiness Wire

    Veradigm Brings Patient Voice to Healthcare Research with New Real-World Data Survey Solution

  • Press releaseBusiness Wire

    Veradigm to Release Business Update February 17th and Host Investor Call February 18th

  • Press releaseBusiness Wire

    Veradigm Extends Stockholder Rights Plan

  • Press releaseBusiness Wire

    Veradigm Launches New AI Application for Powerful Revenue Cycle Insights for Independent Practices

  • Press releaseBusiness Wire

    Veradigm and Meperia Launch Industry-First 8-Way Match EDI Platform to Strengthen Healthcare Supply Chain Integrity

  • Press releaseBusiness Wire

    Veradigm Launches Enhanced Ambient Scribe Capabilities

  • Press releaseBusiness Wire

    Veradigm Adds Sentara Health Plans to Veradigm Payer Insights Solution

  • Press releaseBusiness Wire

    Veradigm Appoints Tehsin Syed as Chief Product and Technology Officer

  • Press releaseBusiness Wire

    Veradigm Provides 2025 Business Update

  • Press releasePRNewswire

    Practice Management Systems Market is Projected to Reach US$36.33 billion at CAGR of 9.3% Amid Need for Operational Efficiency & Automation | The Insight Partners

  • Press releasePRNewswire

    Lucid Diagnostics Appoints Healthcare Industry Veteran John R. Palumbo to Board of Directors

  • Press releaseBusiness Wire

    Veradigm Amends and Extends Stockholder Rights Plan

  • Press releaseBusiness Wire

    Veradigm Appoints Don Trigg as Chief Executive Officer

  • Press releaseBusiness Wire

    Veradigm Provides 2025 Financial & Business Update

  • Press releaseBusiness Wire

    Veradigm Advances GLP-1 Real-World Evidence Generation with AI-Driven EHR Data Curation

  • Press releaseBusiness Wire

    STAAR Surgical Announces Changes to Board of Directors

  • Press releaseBusiness Wire

    Black Book Ranks Veradigm Payer Analytics the #1 Overall Payer Analytics Solution Vendor in 2025

  • Press releaseBusiness Wire

    Veradigm Files Fiscal 2022 Form 10-K and Restated Financial Statements

  • Press releaseBusiness Wire

    Black Book Ranks Veradigm EHR the #1 Ambulatory EHR for Family Practice and Primary Care Practices

  • Press releaseBusiness Wire

    Veradigm Advances Deeper Clinical Insights Through NLP-Enhanced EHR Data

  • Press releaseBusiness Wire

    Veradigm Ranked Top Vendor by KLAS

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.